E. Butler

发表

Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients.

E. B. Butler, T. Wheeler, B. Miles, 2004, International journal of radiation oncology, biology, physics.

Radiotherapy in the Management of Prostate Cancer

E. B. Butler, M. Chua, J. Murgić, 2017 .

Serum testosterone level after intensity-modulated radiotherapy in low-risk prostate cancer patients: does testicular dose correlate with testosterone level?

E. B. Butler, Bo Xu, B. Teh, 2012, Journal of Radiation Oncology.

Cytokine Gene Therapy for Genitourinary Cancer

E. B. Butler, T. Wheeler, B. Miles, 2007 .

Malignant meningioma: An indication for initial aggressive surgery and adjuvant radiotherapy

E. B. Butler, R. Grossman, J. Thornby, 2004, Journal of Neuro-Oncology.

Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer.

P. Scardino, B. Miles, T. Thompson, 2000, The Journal of urology.

Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.

E. B. Butler, W. Grant, P. Gildenberg, 2004, International journal of radiation oncology, biology, physics.

Controversies in the Management of Solid Tumor Bone Metastases

E. B. Butler, B. Teh, A. Farach, 2019, Controversies in Radiation Oncology.

Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.

E. B. Butler, W. Grant, A. Frolov, 2003, International journal of radiation oncology, biology, physics.

Treatment of acoustic neuroma: stereotactic radiosurgery vs. microsurgery.

E. B. Butler, L. S. Carpenter, S. Woo, 2001, International journal of radiation oncology, biology, physics.

Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.

E. B. Butler, T. Wheeler, B. Miles, 2004, International journal of radiation oncology, biology, physics.

Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy.

T. Wheeler, B. Miles, C. Ren, 2001, Human gene therapy.

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report.

E. B. Butler, T. Wheeler, B. Miles, 2001, International journal of radiation oncology, biology, physics.

Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy.

E. B. Butler, Ying Huang, B. Teh, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer model.

E. B. Butler, M. Ittmann, T. Thompson, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity.

E Brian Butler, Bin S Teh, E. B. Butler, 2002, International journal of radiation oncology, biology, physics.

Radiation dose in neoadjuvant chemoradiation therapy for esophageal cancer: patterns of care and outcomes from the National Cancer Data Base.

B. Teh, V. Verma, W. Haque, 2018, Journal of gastrointestinal oncology.

Expanding the Therapeutic Index of Radiation Therapy by Combining In Situ Gene Therapy in the Treatment of Prostate Cancer

E. B. Butler, T. Wheeler, M. Tetzlaff, 2006, Technology in cancer research & treatment.

Versatility of the Novalis System to Deliver Image-Guided Stereotactic Body Radiation Therapy (SBRT) for Various Anatomical Sites

E Brian Butler, Susan Richardson, Charles Bloch, 2007, Technology in cancer research & treatment.

Personalized Radiation Therapy for Breast Cancer

W. Haque, Bin S. Teh, E. Butler, 2024, Current oncology.

The role of adjuvant chemotherapy in locally advanced bladder cancer

E. B. Butler, B. Teh, G. D. Lewis, 2017, Acta oncologica.

Impact of setup uncertainty in the dosimetry of prostate and surrounding tissues in prostate cancer patients treated with Peacock/IMRT.

E Brian Butler, Salahuddin Ahmad, Bin S Teh, 2005, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease.

E. B. Butler, W. Grant, T. Wheeler, 2003, International journal of radiation oncology, biology, physics.

The Role of Adjuvant Radiotherapy in the Treatment of Pleural Mesothelioma

B. Teh, A. Farach, S. Dalwadi, 2019, Annals of Surgical Oncology.

A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases

E. B. Butler, S. Lo, R. Amato, 2012, Acta oncologica.

[Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond].

E. B. Butler, B. Butler, B. Teh, 2008, Ai zheng = Aizheng = Chinese journal of cancer.

Does the "peacock" have anything to do with radiotherapy?

E. B. Butler, W. Grant, S. Woo, 1994, International journal of radiation oncology, biology, physics.

The role of combined radiation and immunotherapy in breast cancer treatment

E. B. Butler, Jenny C. Chang, M. Farach-Carson, 2015, Journal of Radiation Oncology.